About this episode

This episode discusses the advancements in FSGS drug development following the approval of Sparsentan.

Topics covered

• FSGS
• drug development
• Sparsentan
• medicine

Keywords

• FSGS
• Sparsentan
• drug approval
• medical advancements

More episodes of HCPLive Podcasts

• Liver Lineup: Closing the Gap in Women’s Liver Health · April 16, 2026 · 45 min
• Liver Lineup: Navigating Genetic Testing in Cholestatic Liver Disease · April 7, 2026 · 56 min
• HCPLive 5 Stories in Under 5: Week of 03/08 · March 15, 2026 · 5 min
• HCPLive 5 Stories in Under 5: Week of 02/15 · February 23, 2026 · 6 min
• ICD-10 Adoption and the True Burden of Short Bowel Syndrome With Alan Buchman, MD, MSPH · February 18, 2026 · 7 min
• When Platelet Increments Matter, With Ruchika Goel, MD · February 12, 2026 · 7 min

Explore listener stats, chart rankings, contacts and more on the HCPLive Podcasts podcast page.